Plunkett Research Online: Ionis Pharmaceuticals Inc

IONIS PHARMACEUTICALS INC (IONS:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought.....



Ionis Pharmaceuticals Inc
Ticker: IONS
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 760 931-9200
Fax: 760 931-9639
Address: 2855 Gazelle Court
Carlsbad, CA 92010 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Antisense Technology
Antisense Technology
Small-Molecule Drugs
Drug Discovery
Drug Development
Drug Commercialization
Contacts Description
Brett MoniaCEO/Director
Elizabeth HougenCFO/Chief Accounting Officer/Executive VP, Divisional
See More
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought.....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
SPINRAZA
TEGSEDI
WAYLIVRA
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: